Contact this trialFirst, we need to learn more about you.
PD-1 Inhibitor
Pembrolizumab + Olaparib/Pemetrexed for Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Knoxville, Tennessee
This trial will compare two different treatments for non-small cell lung cancer. One treatment is pembrolizumab plus maintenance olaparib, and the other is pembrolizumab plus maintenance pemetrexed. The study will look at how well each treatment works and how long each treatment lasts.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.